A PEG ratio for BHC is unavailable at present - the current PE ratio is not present. Prior to the current period, Bausch Health Companies's PEG ratio was 0.04 (December 2025).
Looking at the last nine years, BHC's PEG ratio has has been around 0.14 on average. Within the last nine years, the Jun 2022 quarter recorded the highest PEG value at 0.62. At 0.02, the Sep 2017 quarter showed the minimum PEG ratio in this period.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.04 | 16.55 | 423.1% |
| 2024 | N/A | N/A | 92% |
| 2023 | N/A | N/A | -161.3% |
| 2022 | N/A | N/A | 76.5% |
| 2021 | N/A | N/A | -67.1% |
| 2020 | N/A | N/A | 68.9% |
| 2019 | N/A | N/A | 57% |
| 2018 | N/A | N/A | -272.2% |
| 2017 | 0.02 | 3.03 | 198.8% |
| 2016 | N/A | N/A | -716.5% |
| 2015 | N/A | N/A | -132.3% |
| 2014 | 0.28 | 54.41 | 197.4% |
| 2013 | N/A | N/A | -610.5% |
| 2012 | N/A | N/A | -173.1% |
| 2011 | 0.6 | 89.79 | 149.1% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | N/A | -2,854.5% |
| Dec 2025 | 0.04 | 16.55 | 423.1% |
| Sep 2025 | 0.02 | 6.65 | 306.4% |
| Jun 2025 | 0.21 | 25.62 | 120.5% |
| Mar 2025 | N/A | N/A | 91.1% |
| Dec 2024 | N/A | N/A | 92% |
| Sep 2024 | N/A | N/A | 82.2% |
| Jun 2024 | N/A | N/A | -149% |
| Mar 2024 | N/A | N/A | -25.5% |
| Dec 2023 | N/A | N/A | -161.3% |
| Sep 2023 | N/A | N/A | -471.8% |
| Jun 2023 | N/A | N/A | -492.3% |
| Mar 2023 | N/A | N/A | 13.3% |
| Dec 2022 | N/A | N/A | 76.5% |
| Sep 2022 | 0.08 | 9.7 | 121.6% |
| Stock name | PEG ratio | Market cap |
|---|---|---|
| OPK Opko Health Inc | N/A | $921.21M |
| ORGO Organogenesis Holdings Inc | N/A | $307.53M |
| BHC Bausch Health Companies Inc | N/A | $1.65B |
A PEG ratio is not computable for BHC - the PE ratio data is negative or zero.
BHC has a 5-year average PEG ratio of 0.19.
The Jun 2022 quarter marked the nine years high at 0.62 for BHC's PEG ratio.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.